References

1. Malhotra A, White D. Seminar: Obstructive Sleep Apnoea. The Lancet 2002; 360:237-245.

2. Teran-Santos J et alThe association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. NEJM 1999; 340(11):847-51.

3. Brooks D, et al Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. JCI 1997; 99(1):106-9.

4. Lavie P et al Obstructive Sleep Apnea Syndrome as a Risk Factor for Hypertension. Brit. Med. J. 2000; 320:479-482.

5. Nieto F et al Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283:1829-1836.

6. Peppard P et al Prospective study of the association between sleep disordered breathing and hypertension. NEJM 2000; 342:1378-1384.

7. Faccenda JF et al Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. AJRCCM 2001; 163(2):344-8.

8. Becker H et al Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107:68-73.

9. Pepperell JC et al Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359:204-10.

10. JNC-7. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.

11. Shahar E et al Sleep-disordered Breathing and Cardiovascular Disease . Cross-sectional Results of the Sleep Heart Health Study. AJRCCM2001; 163:19-25.

12. Young T et al The occurrence of sleep-disordered breathing among middle-aged adults. NEJM 1993; 32:1230-1235.

13. Flier J. Obesity Wars: Molecular Progress Confronts an Expanding Epidemic. 116 2004:337-350.

14. Hosselet JJ et al Detection of flow limitation with a nasal cannula/pressure transducer. AJRCCM1998; 157(5 Pt 1):1461-7.

15. Moyer C et al  Quality of life in obstructive sleep apnea: a systematic review of the literature. Sleep Med. 2001; 2:477-491.

16. Stradling J, Davies R. Sleep. 1: Obstructive sleep apnoea/hypopnoea syndrome: definitions, epidemiology, and natural history. Thorax 2004; 59:73-78.

17. Logan AG et al High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001; 19(12):2271-7.

18. Logan A et al Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. ERJ 2003; 21:241-247.

19. Young T et al Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. AJRCCM 2003; 167:1181-1185.

20. Jordan A, McEvoy D. Gender differences in sleep apnea: epidemiology, clinical presentation and pathogenic mechanisms. Sleep Med. Rev. 2003; 7:377-389.

21. Javaheri S et al Sleep apnea in 81 ambulatory male patients with stable heart failure. Circulation 1998; 97:2154-9.

22. Sin D et al Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. AJRCCM 1999; 160:1101-1106.

23. Leung R et al Sleep apnea and cardiovascular disease. Am J Resp Crit Care Med 2001; 164:2147-2165.

24. Lanfranchi PA et al Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999; 99(11):1435-40.

25. Solin P et al Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999; 99(12):1574-9.

26. Malhotra A et al. Clinical Pathological Case. New Engl. J. Med. 2003.

27. Kaneko Y et al Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. NEJM 2003; 348:1233-1241.

28. Mansfield D et alControlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. AJRCCM 2004; 169:361-366.

29. Naughton MT et al Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. AJRCCM 1995; 152(2):473-9.

30. Kaye D et al Continuous positive airway pressure reduces myocardial oxygen consumption in heart failure. Clin. Sci. 2004:in press.

31. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000; 101:392-397.

32. Andreas S, et al Improvement of exercise capacity with treatment of cheyne-stokes respiration in patients with congestive heart failure. JACC1996; 27:1486-1490.

33. Sin D et al Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102:61-66.